{"disease":{"id":"influenza-a-h5n1","name":"influenza a h5n1"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03497845","title":"Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Biomedical Advanced Research and Development Authority","has_results":true},{"nct_id":"NCT07516418","title":"Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":570,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT01086657","title":"An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00408109","title":"Safety Study of Avian Flu Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00489931","title":"Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03651544","title":"The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false},{"nct_id":"NCT03701061","title":"Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Emory University","has_results":true}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}